Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.4 Purchased database
1.5 GVR’s internal database
1.6 Secondary sources & third party perspectives
1.7 Primary research
1.8 Information analysis
1.9 Data analysis models
1.10 Market formulation & data visualization
1.11 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Neurostimulation Devices Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Product Pipeline Analysis, by Stage
3.4 Industry Value Chain Analysis
3.4.1 Cost Structure Analysis
3.4.2 User Perspective Analysis
3.4.2.1 Consumer behavior analysis
3.4.2.2 Market influencer analysis
3.4.3 Cost Analysis Breakdown
3.4.4 List Of Key End Users, By Region
3.5 Technology Overview
3.5.1 Technology Timeline
3.6 Regulatory Framework
3.6.1 Reimbursement Framework
3.6.2 Standards And Compliances
3.7 Market Dynamics
3.7.1 Market Driver Analysis
3.7.1.1 Growing geriatric population base
3.7.1.2 Introduction of technological advancements
3.7.1.3 Growing demand for neurostimulation devices as an add on therapy
3.7.1.4 Increasing global prevalence of chronic diseases
3.7.1.5 Growing prevalence of lifestyle-induced disorders
3.7.1.6 External funding for executing research and development exercises
3.7.1.7 Growing demand for minimally invasive surgeries
3.7.2 Market Restraint Analysis
3.7.2.1 Adverse effects and risks associated with neurostimulation devices
3.7.2.2 Presence of stringent device approval regulations
3.7.2.3 Availability of external substitutes or alternative therapeutic procedures
3.7.3 Industry Challenges
3.7.3.1 Presence of ambiguous regulatory framework
3.8 Neurostimulation Devices Market Analysis Tools
3.8.1 Industry Analysis – PORTER’S
3.8.1.1 Supplier Power
3.8.1.2 Buyer Power
3.8.1.3 Substitution Threat
3.8.1.4 Threat from new entrants
3.8.1.5 Competitive Rivalry
3.8.2 PESTEL Analysis
3.8.2.1 Political Landscape
3.8.2.2 Environmental Landscape
3.8.2.3 Social landscape
3.8.2.4 Technology landscape
3.8.2.5 Legal Landscape
3.8.3 Major Deals And Strategic Alliances Analysis
3.8.3.1 Joint ventures
3.8.3.2 Mergers and acquisitions
3.8.3.3 Licensing and partnership
3.8.3.4 Technology collaborations
3.8.3.5 Strategic Divestments
3.8.4 Market Entry Strategies
3.8.5 Case Studies
Chapter 4 Neurostimulation Devices Market – Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.3.3 Key Company Market Share Analysis, 2022
4.4 Public Companies
4.4.1 Company Market Position Analysis
4.4.2 Company Market Share, By Region
4.4.3 Competitive Dashboard Analysis
4.4.3.1 Market Differentiators
4.4.3.2 Synergy Analysis: Major Deals And Strategic Alliances
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.5.2 Regional Network Map
4.5.3 Company Market Position Analysis
4.5.4 Supplier Ranking
Chapter 5 Neurostimulation Devices Market: Product Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Product Market Share Analysis, 2022
5.3 Segment Dashboard
5.4 Global Neurostimulation Devices Market, By Product, 2018 – 2030
5.5 Market Size & Forecasts And Trend Analyses, 2018 – 2030
5.5.1 Spinal Cord Stimulator
5.5.1.1 Spinal Cord Stimulators Market, 2018 – 2030 (USD Million)
5.5.1.2 Spinal Cord Stimulators Market, 2018 – 2030 (‘000 Units)
5.5.1.3 Spinal Cord Stimulator Market, By Application, 2018 – 2030 (USD Million)
5.5.2 Deep Brain Stimulator
5.5.2.1 Deep Brain Stimulators Market, 2018 – 2030 (USD Million)
5.5.2.2 Deep Brain Stimulators Market, 2018 – 2030 (‘000 Units)
5.5.2.3 Deep Brain Stimulators Market, By Application, 2018 – 2030 (USD Million)
5.5.3 Sacral Nerve Stimulators Market
5.5.3.1 Sacral Nerve Stimulators Market, 2018 – 2030 (USD Million)
5.5.3.2 Sacral Nerve Stimulators Market, 2018 – 2030 (‘000 Units)
5.5.3.3 Sacral Nerve Stimulators Market, By Application, 2018 – 2030 (USD Million)
5.5.4 Vagus Nerve Stimulators Market
5.5.4.1 Vagus Nerve Stimulators Market, 2018 – 2030 (USD Million)
5.5.4.2 Vagus Nerve Stimulators Market, 2018 – 2030 (‘000 Units)
5.5.4.3 Vagus Nerve Stimulators, By Application, 2018 – 2030 (USD Million)
5.5.5 Gastric Electric Stimulators Market
5.5.5.1 Gastric Electric Stimulators Market, 2018 – 2030 (USD Million)
5.5.5.2 Gastric Electric Stimulators Market, 2018 – 2030 (‘000 Units)
5.5.5.3 Gastric Electric Stimulators, By Application, 2018 – 2030 (USD Million)
Chapter 6 Neurostimulation Devices Market: Application Estimates And Trend Analysis
6.1 Definition & Scope
6.2 Application Market Share Analysis, 2022
6.3 Segment Dashboard
6.4 Global Neurostimulation Devices Market, By Application, 2018 – 2030
6.5 Market Size & Forecasts And Trend Analyses, 2018 – 2030
6.5.1 Neurostimulation Devices For Pain Management Market
6.5.1.1 Neurostimulation Devices For Pain Management Market, 2018 – 2030 (USD Million)
6.5.2 Neurostimulation Devices For Epilepsy Market
6.5.2.1 Neurostimulation Devices For Epilepsy Market, 2018 – 2030 (USD Million)
6.5.3 Neurostimulation Devices For Essential Tremor Market
6.5.3.1 Neurostimulation Devices For Essential Tremor Market, 2018 – 2030 (USD Million)
6.5.4 Neurostimulation Devices For Urinary And Fecal Incontinence Market
6.5.4.1 Neurostimulation Devices For Urinary And Fecal Incontinence Market, 2018 – 2030 (USD Million)
6.5.5 Neurostimulation Devices For Depression Market
6.5.5.1 Neurostimulation Devices For Depression Market, 2018 – 2030 (USD Million)
6.5.6 Neurostimulation Devices For Dystonia Market
6.5.6.1 Neurostimulation Devices For Dystonia Market, 2018 – 2030 (USD Million)
6.5.7 Neurostimulation Devices For Gastroparesis Market
6.5.7.1 Neurostimulation Devices For Gastroparesis Market, 2018 – 2030 (USD Million)
6.5.8 Neurostimulation Devices For Parkinson’s Disease Market
6.5.8.1 Neurostimulation Devices For Parkinson’s Disease Market, 2018 – 2030 (USD Million)
6.5.9 Neurostimulation Devices For Other Diseases Market
6.5.9.1 Neurostimulation Devices For Other Diseases Market, 2018 – 2030 (USD Million)
Chapter 7 Neurostimulation Devices Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Regional Marketplace: Key Takeaways
7.3. North America
7.3.1. SWOT Analysis
7.3.2. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.3.3. U.S.
7.3.3.1. Country Dynamics
7.3.3.2. Country Variables
7.3.3.3. Competitive Landscape
7.3.3.4. Regulatory/Reimbursement Framework
7.3.3.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.3.4. Canada
7.3.4.1. Country Dynamics
7.3.4.2. Country Variables
7.3.4.3. Competitive Landscape
7.3.4.4. Regulatory/Reimbursement Framework
7.3.4.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. SWOT Analysis
7.4.2. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.4.3. UK
7.4.3.1. Country Dynamics
7.4.3.2. Country Variables
7.4.3.3. Competitive Landscape
7.4.3.4. Regulatory/Reimbursement Framework
7.4.3.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.4.4. Germany
7.4.4.1. Country Dynamics
7.4.4.2. Country Variables
7.4.4.3. Competitive Landscape
7.4.4.4. Regulatory/Reimbursement Framework
7.4.4.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.4.5. France
7.4.5.1. Country Dynamics
7.4.5.2. Country Variables
7.4.5.3. Competitive Landscape
7.4.5.4. Regulatory/Reimbursement Framework
7.4.5.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.4.6. Italy
7.4.6.1. Country Dynamics
7.4.6.2. Country Variables
7.4.6.3. Competitive Landscape
7.4.6.4. Regulatory/Reimbursement Framework
7.4.6.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.4.7. Spain
7.4.7.1. Country Dynamics
7.4.7.2. Country Variables
7.4.7.3. Competitive Landscape
7.4.7.4. Regulatory/Reimbursement Framework
7.4.7.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.4.8. Denmark
7.4.8.1. Country Dynamics
7.4.8.2. Country Variables
7.4.8.3. Competitive Landscape
7.4.8.4. Regulatory/Reimbursement Framework
7.4.8.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.4.9. Sweden
7.4.9.1. Country Dynamics
7.4.9.2. Country Variables
7.4.9.3. Competitive Landscape
7.4.9.4. Regulatory/Reimbursement Framework
7.4.9.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.4.10. Norway
7.4.10.1. Country Dynamics
7.4.10.2. Country Variables
7.4.10.3. Competitive Landscape
7.4.10.4. Regulatory/Reimbursement Framework
7.4.10.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. SWOT Analysis
7.5.2. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.5.3. Japan
7.5.3.1. Country Dynamics
7.5.3.2. Country Variables
7.5.3.3. Competitive Landscape
7.5.3.4. Regulatory/Reimbursement Framework
7.5.3.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.5.4. China
7.5.4.1. Country Dynamics
7.5.4.2. Country Variables
7.5.4.3. Competitive Landscape
7.5.4.4. Regulatory/Reimbursement Framework
7.5.4.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.5.5. India
7.5.5.1. Country Dynamics
7.5.5.2. Country Variables
7.5.5.3. Competitive Landscape
7.5.5.4. Regulatory/Reimbursement Framework
7.5.5.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.5.6. Australia
7.5.6.1. Country Dynamics
7.5.6.2. Country Variables
7.5.6.3. Competitive Landscape
7.5.6.4. Regulatory/Reimbursement Framework
7.5.6.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.5.7. Thailand
7.5.7.1. Country Dynamics
7.5.7.2. Country Variables
7.5.7.3. Competitive Landscape
7.5.7.4. Regulatory/Reimbursement Framework
7.5.7.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.5.8. South Korea
7.5.8.1. Country Dynamics
7.5.8.2. Country Variables
7.5.8.3. Competitive Landscape
7.5.8.4. Regulatory/Reimbursement Framework
7.5.8.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. SWOT Analysis
7.6.2. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.6.3. Brazil
7.6.3.1. Country Dynamics
7.6.3.2. Country Variables
7.6.3.3. Competitive Landscape
7.6.3.4. Regulatory/Reimbursement Framework
7.6.3.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.6.4. Mexico
7.6.4.1. Country Dynamics
7.6.4.2. Country Variables
7.6.4.3. Competitive Landscape
7.6.4.4. Regulatory/Reimbursement Framework
7.6.4.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.6.5. Argentina
7.6.5.1. Country Dynamics
7.6.5.2. Country Variables
7.6.5.3. Competitive Landscape
7.6.5.4. Regulatory/Reimbursement Framework
7.6.5.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. SWOT Analysis
7.7.2. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.7.3. South Africa
7.7.3.1. Country Dynamics
7.7.3.2. Country Variables
7.7.3.3. Competitive Landscape
7.7.3.4. Regulatory/Reimbursement Framework
7.7.3.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.7.4. Saudi Arabia
7.7.4.1. Country Dynamics
7.7.4.2. Country Variables
7.7.4.3. Competitive Landscape
7.7.4.4. Regulatory/Reimbursement Framework
7.7.4.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.7.5. UAE
7.7.5.1. Country Dynamics
7.7.5.2. Country Variables
7.7.5.3. Competitive Landscape
7.7.5.4. Regulatory/Reimbursement Framework
7.7.5.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.7.6. Kuwait
7.7.6.1. Country Dynamics
7.7.6.2. Country Variables
7.7.6.3. Competitive Landscape
7.7.6.4. Regulatory/Reimbursement Framework
7.7.6.5. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
Chapter 8 Company Profiles
8.1 Company Profiles
8.1.1 MEDTRONIC
8.1.1.1 Company overview
8.1.1.2 Financial Performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 ST. JUDE MEDICAL
8.1.2.1 Company overview
8.1.2.2 Financial Performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 BOSTON SCIENTIFIC CORPORATION
8.1.3.1 Company overview
8.1.3.2 Financial Performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 CYBERONICS
8.1.4.1 Company overview
8.1.4.2 Financial Performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 NEVRO CORPORATION
8.1.5.1 Company overview
8.1.5.2 Financial Performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 NEURONETICS, INC.
8.1.6.1 Company overview
8.1.6.2 Financial Performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 UROPLASTY
8.1.7.1 Company overview
8.1.7.2 Financial Performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 CODMAN & SHURTLEFF’S
8.1.8.1 Company overview
8.1.8.2 Financial Performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 INTRAPACE
8.1.9.1 Company overview
8.1.9.2 Financial Performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives